This inventor holds 1 USPTO granted patent. Top assignee: Technoderma Medicines Pte Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yuting Cai - Innovator in Small Molecule Compounds
Introduction
Yuting Cai is a notable inventor based in Sichuan, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule compounds. His work focuses on innovative solutions for inhibiting specific kinases, which are crucial in various biological processes.
Latest Patents
Yuting Cai holds a patent for a small molecule compound serving as a JAK kinase inhibitor. The patent describes a compound represented by a specific formula, which includes various stereoisomers, geometric isomers, tautomers, hydrates, solvates, and pharmaceutically acceptable salts or prodrugs. This small molecule compound is designed to inhibit the JAK kinase, with particular applications as a JAK1/Tyk2 dual inhibitor and a Tyk2 specific inhibitor.
Career Highlights
Yuting Cai is currently associated with Technoderma Medicines Pte Ltd., where he continues to advance his research and development efforts. His innovative approach to drug design has positioned him as a key player in the pharmaceutical industry.
Collaborations
Yuting collaborates with talented individuals such as Guanqun Li and Zengquan Wang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yuting Cai's work in developing small molecule compounds exemplifies the impact of innovative research in the pharmaceutical field. His contributions are paving the way for new therapeutic options in the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile